UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Aljian Capital Management LLC

Aljian Capital Management LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 11.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 18,138 shares of the healthcare conglomerate’s stock after purchasing an additional 1,895 shares during the quarter. UnitedHealth Group makes up 2.0% of Aljian Capital Management LLC’s investment portfolio, making the stock its 9th biggest holding. Aljian Capital Management LLC’s holdings in UnitedHealth Group were worth $9,176,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Intelligence Driven Advisers LLC raised its stake in shares of UnitedHealth Group by 9.7% during the 4th quarter. Intelligence Driven Advisers LLC now owns 496 shares of the healthcare conglomerate’s stock worth $251,000 after buying an additional 44 shares in the last quarter. Avestar Capital LLC lifted its stake in shares of UnitedHealth Group by 7.6% during the fourth quarter. Avestar Capital LLC now owns 7,304 shares of the healthcare conglomerate’s stock valued at $3,695,000 after buying an additional 518 shares during the period. Hemington Wealth Management increased its stake in UnitedHealth Group by 5.9% in the fourth quarter. Hemington Wealth Management now owns 1,126 shares of the healthcare conglomerate’s stock valued at $569,000 after purchasing an additional 63 shares during the last quarter. Ingalls & Snyder LLC raised its stake in UnitedHealth Group by 1.7% during the fourth quarter. Ingalls & Snyder LLC now owns 8,670 shares of the healthcare conglomerate’s stock worth $4,386,000 after purchasing an additional 143 shares during the period. Finally, McClarren Financial Advisors Inc. increased its stake in UnitedHealth Group by 62.7% during the fourth quarter. McClarren Financial Advisors Inc. now owns 1,533 shares of the healthcare conglomerate’s stock worth $775,000 after acquiring an additional 591 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $527.31 on Thursday. The company has a 50-day moving average of $524.58 and a two-hundred day moving average of $563.71. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market cap of $485.27 billion, a price-to-earnings ratio of 34.02, a PEG ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the previous year, the company posted $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. Bank of America lowered their target price on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, UBS Group cut their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $629.32.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.